Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Graessler, Juergen ^a   Schwudke, Dominik ^b,c   Schwarz, Peter E H ^a   Herzog, Ronny ^a,b   Schevchenko, Andrej ^b   Bornstein, Stefan R ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^c TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIACYLGLYCEROL; INSULIN; LIPID; LIPIDOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPIDOMICS; MALE; MASS SPECTROMETRY; OBESITY; SCREENING; BLOOD; CHEMISTRY; METABOLISM; MIDDLE AGED;

HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPIDS; MALE; MASS SPECTROMETRY; MIDDLE AGED; OBESITY;

EID: 67650669263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006261     Document Type: Article

References (47)

1. Castelli WP, Anderson K (1986) A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 80: 23-32.
2. Neutel JM, Smith DH (1998) Hypertension: where have we gone wrong and how can we fix it? Am J Hypertens 11: 150S-157S.
3. Reaven GM (1991) Relationship between insulin resistance and hypertension. Diabetes Care 14 Suppl 4: 33-38.
4. Bo S, Gambino R, Gentile L, Pagano G, Rosato R, et al. (2009) High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study. J Hypertens 27: 102-108.
5. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS (2008) Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 207: 928-934.
6. Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, et al. (2009) Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 10: 549-555.
7. Sironi AM, Pingitore A, Ghione S, De Marchi D, Scattini B, et al. (2008) Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 51: 282-288.
8. Sima AV, Stancu CS, Simionescu M (2009) Vascular endothelium in atherosclerosis. Cell Tissue Res 335: 191-203.
9. Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, et al. (2006) Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients. Diabetes Care 29: 195-201.
10. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, et al. (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361: 1149-1158.
11. Sysi-Aho M, Vehtari A, Velagapudi VR, Westerbacka J, Yetukuri L, et al. (2007) Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles. Bioinformatics 23: i519-528.
12. Sysi-Aho M, Katajamaa M, Yetukuri L, Oresic M (2007) Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinformatics 8: 93.
13. Hermansson M, Uphoff A, Kakela R, Somerharju P (2005) Automated quantitative analysis of complex lipidomes by liquid chromatography/mass spectrometry. Anal Chem 77: 2166-2175.
14. Haimi P, Uphoff A, Hermansson M, Somerharju P (2006) Software tools for analysis of mass spectrometric lipidome data. Anal Chem 78: 8324-8331.
15. Ding J, Sorensen CM, Jaitly N, Jiang H, Orton DJ, et al. (2008) Application of the accurate mass and time tag approach in studies of the human blood lipidome. J Chromatogr B Analyt Technol Biomed Life Sci 871: 243-252.
16. Houjou T, Yamatani K, Imagawa M, Shimizu T, Taguchi R (2005) A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 19: 654-666.
17. Liebisch G, Lieser B, Rathenberg J, Drobnik W, Schmitz G (2004) High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta 1686: 108-117.
18. Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B, et al. (2006) High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim Biophys Acta 1761: 121-128.
19. Schwudke D, Liebisch G, Herzog R, Schmitz G, Shevchenko A (2007) Shotgun lipidomics by tandem mass spectrometry under data-dependent acquisition control. Methods Enzymol 433: 175-191.
20. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49: 1137-1146.
21. Schwudke D, Oegema J, Burton L, Entchev E, Hannich JT, et al. (2006) Lipid profiling by multiple precursor and neutral loss scanning driven by the data-dependent acquisition. Anal Chem 78: 585-595.
22. Ejsing CS, Duchoslav E, Sampaio J, Simons K, Bonner R, et al. (2006) Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal Chem 78: 6202-6214.
23. Ejsing CS, Sampaio JL, Surendranath V, Duchoslav E, Ekroos K, et al. (2009) Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc Natl Acad Sci U S A 106: 2136-2141.
24. Schwudke D, Hannich JT, Surendranath V, Grimard V, Moehring T, et al. (2007) Top-down lipidomic screens by multivariate analysis of high-resolution survey mass spectra. Anal Chem 79: 4083-4093.
25. Pietilainen KH, Sysi-Aho M, Rissanen A, Seppanen-Laakso T, Yki-Jarvinen H, et al. (2007) Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoSONE 2: e218.
26. Schwab U, Seppanen-Laakso T, Yetukuri L, Agren J, Kolehmainen M, et al. (2008) Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - the GENOBIN study. PLoSONE 3: e2630.
27. Bergmann A, Li J, Selisko T, Reimann M, Fischer S, et al. (2008) The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF-1alpha) is associated with insulin sensitivity and beta-cell function. Exp Clin Endocrinol Diabetes 116 Suppl 1: S50-55.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
29. Ejsing CS, Moehring T, Bahr U, Duchoslav E, Karas M, et al. (2006) Collision-induced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion trap-orbitrap mass spectrometry. J Mass Spectrom 41: 372-389.
30. Ekroos K, Ejsing CS, Bahr U, Karas M, Simons K, et al. (2003) Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation. J Lipid Res 44: 2181-2192.
31. Zemski Berry KA, Murphy RC (2004) Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrom 15: 1499-1508.
32. Seidell JC, Cigolini M, Charzewska J, Ellsinger BM, Bjorntorp P, et al. (1991) Fat distribution and gender differences in serum lipids in men and women from four European communities. Atherosclerosis 87: 203-210.
33. Lima NK, Abbasi F, Lamendola C, Reaven GM (2009) Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 22: 106-111.
34. Yamagishi K, Nettleton JA, Folsom AR (2008) Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156: 965-974.
35. Ehrhart-Bornstein M, Arakelyan K, Krug AW, Scherbaum WA, Bornstein SR (2004) Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 30: 865-870.
36. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, et al. (2003) Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100: 14211-14216.
37. Kopprasch S, Pietzsch J, Ansurudeen I, Graessler J, Krug AW, et al. (2009) Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion. J Endocrinol 200: 45-52.
38. McGowan HM, Vandongen R, Kelly LD, Hill KJ (1988) Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. Clin Sci (Lond) 74: 393-396.
39. Blank ML, Hall MN, Cress EA, Snyder F (1983) Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun 113: 666-671.
40. Harayama T, Shindou H, Ogasawara R, Suwabe A, Shimizu T (2008) Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor. J Biol Chem 283: 11097-11106.
41. Maeba R, Maeda T, Kinoshita M, Takao K, Takenaka H, et al. (2007) Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging. J Atheroscler Thromb 14: 12-18.
42. Ponnuchamy B, Khalil RA (2009) Cellular Mediators of Renal Vascular Dysfunction in Hypertension. Am J Physiol Regul Integr Comp Physiol 296: R1001-1018.
43. Seubert JM, Sinal CJ, Graves J, DeGraff LM, Bradbury JA, et al. (2006) Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99: 442-450.
44. Vanhoutte PM (2009) Endothelial Dysfunction. Circ J 73: 595-601.
45. Kolodgie FD, Burke AP, Nakazawa G, Cheng Q, Xu X, et al. (2007) Free cholesterol in atherosclerotic plaques: where does it come from? Curr Opin Lipidol 18: 500-507.
46. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G (2009) Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50: 574-585.
47. Dullaart RP, Perton F, Sluiter WJ, de Vries R, van Tol A (2008) Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. J Clin Endocrinol Metab 93: 4860-4866.